Race Oncology Ltd (ASX:RAC) Receives $5.25m R&D Tax Refund

R&D Tax Refund Announcement

Race Oncology Limited (ASX:RAC) has received a refund of $5,254,557 through the Australian Government’s Research & Development (R&D) Tax Incentive scheme for the financial year 2024. This incentive aims to encourage innovation within the Australian industry by providing tax offsets of up to 43.5% on eligible R&D expenditure.

Overseas R&D Activities

On 2 September 2024, Race Oncology also secured a positive determination from AusIndustry for eligibility regarding overseas R&D activities, resulting in an R&D Tax Incentive Advance and Overseas Finding Assessment of up to $20,081,627 over three years. This binding assessment confirms that Race’s R&D efforts are deemed of national interest and extends the generous R&D rebate to cover activities performed outside Australia from 1 July 2023 to 30 June 2026.

CEO Comments

Dr Daniel Tillett, CEO and Managing Director of Race, stated, “The Australian government’s R&D tax incentive program plays a critical role in helping Australian research-intensive companies to innovate. This incentive is especially important in helping biopharmaceutical companies such as Race Oncology solve significant unmet needs for patients. We are grateful to receive this refund and look forward to utilising the funds to accelerate the clinical development of RC220.”

View Original Announcement

here

Motley Fool contributor Lianne Eastty has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

This article was generated using GPT-4o mini, a Large Language Model (LLM), to generate summaries of investing news. While AI is generating the content, we know better than to blindly trust our future robot overlords, and every article is edited and fact-checked by an editor holding the appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content of everything published by The Capital Club.